Q1 2022 Holdings
Filed 2022-05-16 | 135 holdings | $672.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $110.4M | 350,000 | 16.4% |
| Align Technology Inc(ALGN) | COM | 016255101 | $94.4M | 216,500 | 14.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $77.6M | 2,665,275 | 11.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $66.6M | 3,865,034 | 9.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $54.3M | 332,500 | 8.1% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $49.4M | 753,500 | 7.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $49.0M | 417,500 | 7.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $30.8M | 457,600 | 4.6% |
| Conmed Corp(CNMD) | COM | 207410101 | $30.1M | 202,500 | 4.5% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $22.2M | 1,008,114 | 3.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $20.4M | 264,500 | 3.0% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $14.8M | 725,000 | 2.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $12.8M | 998,307 | 1.9% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $9.5M | 771,018 | 1.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $7.3M | 5,328,088 | 1.1% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $6.8M | 652,578 | 1.0% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $5.2M | 1,165,582 | 0.8% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $4.7M | 2,297,194 | 0.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.3M | 97,317 | 0.5% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $193.7K | 7,640,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $160.4K | 368,600 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $128.3K | 481,700 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $122.4K | 240,000 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $119.7K | 218,750 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $103.6K | 1,105,000 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $94.0K | 375,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $90.1K | 298,500 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $78.5K | 746,000 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $76.9K | 2,380,000 | 0.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $76.3K | 1,000,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $76.3K | 2,552,034 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $74.7K | 1,028,109 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $70.2K | 596,500 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $68.7K | 436,000 | 0.0% |
| Freshpet Inc(FRPT) | COM | 358039105 | $60.8K | 592,500 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $60.5K | 947,715 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $60.3K | 1,723,341 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $58.2K | 750,700 | 0.0% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $56.3K | 271,500 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $54.8K | 432,543 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $53.2K | 104,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $53.0K | 1,205,900 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $52.2K | 721,500 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $46.0K | 559,734 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $45.4K | 204,500 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $39.9K | 570,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $39.0K | 270,500 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $37.7K | 1,174,786 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $36.7K | 1,666,208 | 0.0% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $35.7K | 502,500 | 0.0% |